AP02 (Nintedanib Solution)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AP02 (Nintedanib Solution), covering 2026-04-06 to 2026-04-06. Get the full timeline:
Most recent: Clinical Trial Update: AURA-IPF: A Randomized Phase 2 Study to Evaluate the Safety and Efficacy of AP02 (Nintedanib Solution) in IPF [Phase 2]